Niven Rajin Narain

This inventor holds 51 USPTO granted patents and 73 published patent applications, plus 16 CIPO patents and 27 EPO patents, primarily in Oncological Disorders. Top assignees: Berg LLC, Bpgbio, Inc., University of Miami. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niven Rajin Narain. Retrieved from https://idiyas.com/inventor/niven-rajin-narain

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 51 (Patent Applications = 73)

% Patents Active = 84.3

CIPO Patents = 16 (Patent Applications = 25)

EPO Patents = 27 (Patent Applications = 51)

Average Co-Inventor Count = 3.3

ph-index = 11

Forward Citations = 322(Granted Patents)

Location History:

Miami, FL (US) (2012 - 2020)
Cambridge, MA (US) (2012 - 2023)

Company Filing History:

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

patents

6. 2 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Coenzyme Q10

Oncological Disorders

Prostate Cancer

Epidermolysis Bullosa

Cell-Based Assays

Biochemical Recurrence

Temozolomide

Apoptosis Induction

Heat Shock Protein

Intravenous Formulations

Disease Markers

Cancer Treatment

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12691081 - Methods for the treatment of cancer using coenzyme Q10 combination therapies (2026-07-28),

2. 12653776 - Methods of treatment of cancer by continuous infusion of coenzyme Q10 (2026-06-16),

3. 12626169 - Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data (2026-05-12),

4. 12616666 - Coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa (2026-05-05),

5. 12437835 - Interrogatory cell-based assays and uses thereof (2025-10-07),

6. 12320812 - Markers for the diagnosis of biochemical recurrence in prostate cancer (2025-06-03),

7. 12303471 - Methods of treatment of temozolomide-resistant glioma using coenzyme Q10 (2025-05-20),

8. 12209285 - Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10) (2025-01-28),

9. 11734593 - Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data (2023-08-22),

10. 11694765 - Interrogatory cell-based assays for identifying drug-induced toxicity markers (2023-07-04),

11. 11456054 - Interrogatory cell-based assays and uses thereof (2022-09-27),

12. 11452699 - Method of treating or preventing tumors of the central nervous system (2022-09-27),

13. 11419830 - Use of coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa (2022-08-23),

14. 11400058 - Intravenous formulations of coenzyme Q10 (CoQ10) and methods of use thereof (2022-08-02),

15. 11305016 - Vitamin D3 and analogs thereof for treating alopecia (2022-04-19),

Title: Niven Rajin Narain - Innovative Inventor from Cambridge

Introduction: Niven Rajin Narain is a visionary inventor based in Cambridge, MA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Niven Rajin Narain holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: With a background in engineering and a passion for innovation, Narain has led successful projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Niven Rajin Narain has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life and make a lasting impact on society.

Conclusion: Niven Rajin Narain's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.